Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC Sponsored ADR ( (HLN) ) has issued an announcement.
On August 29, 2025, Haleon plc announced the purchase and cancellation of 2,191,437 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, conducted on August 28, 2025, aims to optimize the company’s capital structure and potentially enhance shareholder value. Following this transaction, Haleon’s registered share capital stands at 8,961,283,874 ordinary shares, with 3,880,205 held as treasury shares, leaving 8,957,403,669 shares with voting rights. This strategic move reflects Haleon’s commitment to maintaining a robust financial position and could influence its market standing and investor relations.
The most recent analyst rating on (HLN) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
Haleon PLC’s overall stock score reflects strong financial performance and efficient cash flow generation, offset by mixed technical indicators and moderate valuation. The earnings call provided a balanced view of strengths in international markets and challenges in North America. The company’s ability to navigate these challenges and capitalize on growth opportunities will be crucial for future performance.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse product portfolio across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon’s well-known brands, such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, are recognized for their trusted science, innovation, and deep human understanding.
Average Trading Volume: 12,120,224
Technical Sentiment Signal: Buy
Current Market Cap: $43.54B
For an in-depth examination of HLN stock, go to TipRanks’ Overview page.